|
Volumn 106, Issue 1, 2015, Pages 8-
|
Status of P2Y12 treatment must be considered in evaluation of myocardial ischaemia/reperfusion injury
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLOPIDOGREL;
PURINERGIC P2Y12 RECEPTOR;
ACUTE HEART INFARCTION;
CORONARY ARTERY;
HEART CATHETERIZATION;
HEART PROTECTION;
HUMAN;
LETTER;
NONHUMAN;
PERCUTANEOUS CORONARY INTERVENTION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REPERFUSION INJURY;
ANIMAL;
EVALUATION STUDY;
MYOCARDIAL ISCHEMIA;
TRANSLATIONAL RESEARCH;
ANIMALS;
EVALUATION STUDIES AS TOPIC;
MYOCARDIAL ISCHEMIA;
TRANSLATIONAL MEDICAL RESEARCH;
|
EID: 84926676612
PISSN: 00086363
EISSN: 17553245
Source Type: Journal
DOI: 10.1093/cvr/cvv051 Document Type: Letter |
Times cited : (5)
|
References (6)
|